Mafauzy Mohamed

2.1k total citations
54 papers, 954 citations indexed

About

Mafauzy Mohamed is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Mafauzy Mohamed has authored 54 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Mafauzy Mohamed's work include Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers), Diabetes Treatment and Management (14 papers) and Diabetes Management and Education (13 papers). Mafauzy Mohamed is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers), Diabetes Treatment and Management (14 papers) and Diabetes Management and Education (13 papers). Mafauzy Mohamed collaborates with scholars based in Malaysia, United States and Singapore. Mafauzy Mohamed's co-authors include Siew Pheng Chan, Zanariah Hussein, Yasmin Anum Mohd Yusof, Andi Zulkifli, Noor Fatmawati Mokhtar, M Musalmah, Rosediani Muhamad, Azidah Abdul Kadir, Md Asiful Islam and Fahmida Alam and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Mafauzy Mohamed

50 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mafauzy Mohamed Malaysia 17 610 209 153 113 103 54 954
Zanariah Hussein Malaysia 15 567 0.9× 192 0.9× 152 1.0× 123 1.1× 135 1.3× 63 980
Dara Schuster United States 18 451 0.7× 162 0.8× 259 1.7× 181 1.6× 99 1.0× 33 875
Sidartawan Soegondo Indonesia 14 451 0.7× 111 0.5× 143 0.9× 110 1.0× 124 1.2× 39 810
Ie Byung Park South Korea 18 373 0.6× 111 0.5× 149 1.0× 199 1.8× 96 0.9× 62 829
Xavier Cos Spain 17 739 1.2× 113 0.5× 174 1.1× 170 1.5× 136 1.3× 80 1.1k
Pietro Gallina Italy 16 264 0.4× 142 0.7× 247 1.6× 116 1.0× 126 1.2× 27 987
Roberta Arnoldi Cobas Brazil 16 535 0.9× 146 0.7× 112 0.7× 160 1.4× 166 1.6× 39 989
Harry Glauber United States 17 590 1.0× 254 1.2× 172 1.1× 198 1.8× 221 2.1× 22 1.1k
Ching‐Chu Chen Taiwan 16 305 0.5× 136 0.7× 149 1.0× 224 2.0× 124 1.2× 50 812
Rita A. Gómez‐Díaz Mexico 18 312 0.5× 111 0.5× 131 0.9× 101 0.9× 132 1.3× 69 780

Countries citing papers authored by Mafauzy Mohamed

Since Specialization
Citations

This map shows the geographic impact of Mafauzy Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mafauzy Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mafauzy Mohamed more than expected).

Fields of papers citing papers by Mafauzy Mohamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mafauzy Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mafauzy Mohamed. The network helps show where Mafauzy Mohamed may publish in the future.

Co-authorship network of co-authors of Mafauzy Mohamed

This figure shows the co-authorship network connecting the top 25 collaborators of Mafauzy Mohamed. A scholar is included among the top collaborators of Mafauzy Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mafauzy Mohamed. Mafauzy Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohamed, Mafauzy, et al.. (2025). Systematic Review of Advanced Inflammatory Markers as Predictors of Cardiovascular Diseases. Research in Cardiovascular Medicine. 14(1). 8–14.
2.
Mohamed, Mafauzy, Kalpana Bhaskaran, Joel Neutel, et al.. (2023). A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes. Diabetes Therapy. 14(4). 749–766. 8 indexed citations
3.
Mohamed, Mafauzy, et al.. (2023). Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-Interventional Real-World Study. Journal of the ASEAN Federation of Endocrine Societies. 38(1). 37–44. 2 indexed citations
4.
Ahmad, Wan Azman Wan, Azhari Rosman, Sunita Bavanandan, et al.. (2023). Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective. Malaysian Journal of Medical Sciences. 30(1). 67–81.
5.
Chan, Siew Pheng, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, et al.. (2023). Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia. Malaysian Family Physician. 18. 31–31.
6.
7.
Alam, Fahmida, Md Asiful Islam, Mafauzy Mohamed, et al.. (2019). Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Scientific Reports. 9(1). 5389–5389. 77 indexed citations
8.
Stein, Evan A., Eldad J. Dann, Albert Wiegman, et al.. (2017). Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations. Journal of the American College of Cardiology. 70(9). 1162–1170. 36 indexed citations
9.
Mohamed, Mafauzy, et al.. (2016). DiabCare 2013: A cross-sectional study of hospital based diabetes care delivery and prevention of diabetes related complications in Malaysia.. PubMed. 71(4). 177–185. 17 indexed citations
10.
Stein, Evan A., Eldad J. Dann, Albert Wiegman, et al.. (2016). A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, CROSS-OVER STUDY OF ROSUVASTATIN IN CHILDREN AND ADOLESCENTS (AGED 6 TO <18 YEARS) WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH). Journal of the American College of Cardiology. 67(13). 1855–1855. 3 indexed citations
11.
12.
Hussein, Zanariah, et al.. (2012). A Summary of the Consensus for the Management of Thyroid Disorders in Malaysia. Journal of the ASEAN Federation of Endocrine Societies. 27(1). 40–43. 3 indexed citations
13.
Mohamed, Mafauzy, et al.. (2009). Metabolic syndrome and its characteristics among obese patients attending an obesity clinic.. PubMed. 50(4). 390–4. 24 indexed citations
14.
Mohamed, Mafauzy. (2008). MJMS and the challenges of a research university.. PubMed. 15(4). 8–8. 2 indexed citations
15.
Mohamed, Mafauzy. (2006). Diabetes control and complications in public hospitals in Malaysia.. PubMed. 61(4). 477–83. 41 indexed citations
16.
Chuang, Lee‐Ming, Sidartawan Soegondo, Pradana Soewondo, et al.. (2005). Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Research and Clinical Practice. 71(2). 146–155. 48 indexed citations
17.
Mohamad, W B Wan, et al.. (2002). Effects of sulbutiamine on diabetic polyneuropathy: an open randomised controlled study in type 2 diabetics.. PubMed. 9(1). 21–7. 3 indexed citations
18.
Mohamad, W B Wan, et al.. (2000). Efficacy and safety of single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 49(2-3). 93–99. 16 indexed citations
19.
Mohamed, Mafauzy, et al.. (1990). A study of the fasting diabetic patients during the month of Ramadan.. PubMed. 45(1). 14–7. 95 indexed citations
20.
Krishnamurthi, S, et al.. (1989). Cardiomyopathy in pregnancy: 2 case reports.. PubMed. 30(2). 208–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zanariah Hussein Breakdown of academic impact, for papers by Dara Schuster Breakdown of academic impact, for papers by Sidartawan Soegondo Breakdown of academic impact, for papers by Ie Byung Park Breakdown of academic impact, for papers by Xavier Cos Breakdown of academic impact, for papers by Pietro Gallina Breakdown of academic impact, for papers by Roberta Arnoldi Cobas Breakdown of academic impact, for papers by Harry Glauber Breakdown of academic impact, for papers by Ching‐Chu Chen Breakdown of academic impact, for papers by Rita A. Gómez‐Díaz
Rankless by CCL
2026